Tau Marks Reshape Toxic Filaments
2026-10-06
Tau does not merely accumulate; it is edited before it hardens. Under the microscope, filaments resemble spent cables, yet their architecture can shift when phosphorylation, acetylation, or ubiquitination changes tau charge, folding, and access to binding partners. The damage starts quietly. Then neuronal transport and synaptic signaling begin to lose order.
This molecular editing is not a footnote; it may be the story. Cryo-EM studies have shown that tau can form distinct filament folds across neurodegenerative diseases, while post-translational modifications may influence which conformations persist. Not all marks are equal. Phosphorylation can weaken tau's normal association with microtubules, and acetylation may alter degradation or aggregation behavior, creating conditions in which abnormal assemblies gain ground. The result is less a single disease mechanism than a contested chemistry of folds, where one altered protein can leave many structural signatures.
The harder truth is that tau is not simply broken. It is chemically rewritten. In that narrow space between a protective protein and a toxic filament lies a question medicine has not yet answered: which marks are cause, which are consequence, and which become the ink of neuronal loss?
Loading...
